HEMOCEPT Trademark

Trademark Overview

On Thursday, September 1, 2022, a trademark application was filed for HEMOCEPT with the United States Patent and Trademark Office. The USPTO has given the HEMOCEPT trademark a serial number of 97575737. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, May 1, 2025. This trademark is owned by HemoCept, Inc.. The HEMOCEPT trademark is filed in the Medical Instrument Products category with the following description:

Medical devices, namely, non-invasive devices for measurement of cardiovascular status and function
hemocept

General Information

Serial Number97575737
Word MarkHEMOCEPT
Filing DateThursday, September 1, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, May 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2024

Trademark Statements

Goods and ServicesMedical devices, namely, non-invasive devices for measurement of cardiovascular status and function

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, September 21, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHemoCept, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98107
Party NameHemoCept, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98107

Trademark Events

Event DateEvent Description
Wednesday, September 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 5, 2022NEW APPLICATION ENTERED
Friday, June 16, 2023ASSIGNED TO EXAMINER
Friday, June 16, 2023NON-FINAL ACTION WRITTEN
Friday, June 16, 2023NON-FINAL ACTION E-MAILED
Friday, June 16, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 18, 2023ASSIGNED TO LIE
Monday, December 18, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 13, 2024PUBLISHED FOR OPPOSITION
Wednesday, January 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 13, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 9, 2024SOU EXTENSION 1 FILED
Friday, October 11, 2024PETITION TO REVIVE-GRANTED
Friday, October 11, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Friday, October 11, 2024TEAS PETITION TO REVIVE RECEIVED
Friday, October 11, 2024NOTICE OF REVIVAL - E-MAILED
Monday, January 13, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 14, 2025SOU EXTENSION 1 GRANTED
Wednesday, April 9, 2025SOU EXTENSION 2 FILED
Monday, April 28, 2025TEAS PETITION TO REVIVE RECEIVED
Monday, April 28, 2025PETITION TO REVIVE-GRANTED
Monday, April 28, 2025NOTICE OF REVIVAL - E-MAILED
Thursday, May 1, 2025SOU EXTENSION 2 GRANTED
Friday, May 2, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 14, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 28, 2025SOU EXTENSION RECEIVED WITH TEAS PETITION

Related Keywords

hemocept devices status function cardiovascular invasive namely medical measurement